Bernarda Viteri, MD, is studying the benefits of contrast-enhanced ultrasound in kidney transplant patients as well as in children with various kidney conditions.

Researchers found that patients only took less than 25 percent of prescribed amount, and 1 in 5 did not take any opioid medication to manage pain.

Based at CHOP, the Pennsylvania Pediatric Device Consortium (PPDC) announces a partnership with two programs at the University of Pittsburgh.

Dr. Robert Baldassano gives an inside look at unique partnership with PennCHOP Microbiome Program.

Dr. Arunjot Singh talks about the diagnosis and treatment of celiac disease.

An alternative, humanized CD19 CAR T product for first relapse of pediatric ALL is being evaluated in a clinical trial at Children's Hospital of Philadelphia.

Half of parents don’t know their adolescent has had thoughts about suicide, and more than 75 percent of parents are unaware of their adolescent’s thoughts of death and dying.

Learn about CHOP's goal to develop improved, less toxic therapies for pediatric brain tumors by integrating neuro-oncology, neurosurgery, research and big data.

Proton therapy at CHOP helped Elena regain her vision and remain free of craniopharyngioma two years after treatment.

The Healthcare Hero in the field of Cancer was awarded to Phillip “Jay” Storm, MD, for his transformative work in pediatric brain tumor research and care.